The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: Results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial

This publication has 13 references indexed in Scilit:

• Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation
  The American Journal of Cardiology, 2001
• Pharmacologic conversion of atrial fibrillation: A systematic review of available evidence
  Progress in Cardiovascular Diseases, 2001
• Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function
  Circulation, 2001
• Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial
  The Lancet, 2000
• Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response
  Journal of the American College of Cardiology, 2000
• Impact of Atrial Fibrillation on the Risk of Death
  Circulation, 1998
• The Azimilide Post-Infarct Survival Evaluation (ALIVE) Trial
  The American Journal of Cardiology, 1998
• Management of Patients With Atrial Fibrillation
  Circulation, 1996
• Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort
  JAMA, 1994
• Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.
  Circulation, 1994